T-errific T-Regs: Nobel Prize Winning Immune Cells

Unbiased Science

@unbiasedscipod

Education, Science, Health & Fitness

4.4 • 644 Ratings

🗓️ 15 October 2025

⏱️ 33 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this episode, Jess and Sarah welcome Dr. Yasmin Mohseni to discuss the recent Nobel Prize in Medicine awarded for research on regulatory T cells (T-Regs). The conversation explores the significance of T-Regs in immunology, their role in autoimmunity and organ transplantation, and the challenges they present in cancer treatment. Dr. Mohseni shares insights into the future of T-Reg research and the potential for immunotherapy to cure previously incurable diseases, emphasizing the importance of balance in the immune system. Video available on YouTube: https://youtu.be/19r9soRBWDc (00:00) Intro and Public Health Update (02:30) Intro to Dr. Yas (05:41) What Has Caught Dr. Yas Attention In The Public Health Space And Why Should People Care About It? (07:33) What Are TRegs? (10:55) Nobel Prize Winning Research on TRegs And The Implications (17:56) Can TRegs Be Used In Fighting Cancer? (23:34) How Do TRegs "Know" When To Suppress And When Not To? (25:27) What Is The Buzz Right Now In Immunology? (29:59) What Is Giving Hope Right Now In Science/Public Health? @doctor.yas_ on Instagram @doctor-yas on YouTube ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers.

Transcript

Click on a timestamp to play from that location

0:00.0	You're listening to an Airwave Media podcast.
0:27.7	Welcome to Unbiased Science, where we bring scientific method to the madness.
0:32.5	We're your host, Dr. Jess Steyer, and Dr. Sarah Scheinman.
0:40.6	And this week, I am so, so excited to welcome a dear friend, brilliant scientist,
0:44.2	science communicator, Dr. Yasmin Moseni.
0:49.3	And interestingly, we did a total pivot yesterday.
0:56.1	We were supposed to talk about immunotherapies because she's this brilliant badass immunologist.
0:58.7	You'll hear all about her in her background in just a second.
1:07.7	But then the Nobel Prize was announced and it just happens to be in an area that is her expertise.
1:10.8	So we're going to talk all about that in a sec. Before we dive in,
1:13.4	just a super, super quick update in the public health world. So yesterday, so we're recording this,
1:21.5	what is today, Tuesday, October 7th. Yesterday, all these headlines dropped because the CDC finally signed off on the ACIP recommendations
1:31.2	regarding COVID vaccines. As a reminder, ACIP is the advisory committee on immunization practices.
1:37.7	They had their two-day meeting a couple of weeks ago. They talked about lots of things,
1:41.7	including COVID vaccines. And unfortunately, this is getting
1:46.0	interpreted by the media to mean that the federal government is no longer recommending COVID
1:52.0	vaccines, but that is absolutely not the case. COVID vaccines are recommended for everyone six
1:59.0	months and older. The difference now is that we're moving toward
2:04.0	this shared clinical decision making. So it's an individual decision based on your conversation
2:09.9	with your health care provider. But it does not change the fact that the vaccine is still
2:14.7	recommended. You should be able to access a vaccine without a
2:19.6	prescription wherever it is that you live in the United States. So we'll be doing more posts on
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from @unbiasedscipod, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of @unbiasedscipod and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.